Feb 26, 2025 · Medtronic today announced that the first patient has been enrolled in its pivotal trial of the Prevail™ paclitaxel-coated balloon catheter (also known as a drug-coated balloon) …

Feb 26, 2025 · In July 2021, Medtronic announced the launch of the Prevail DCB catheter in Europe after receiving CE Mark approval. The device is commercially available in more than …

Oct 23, 2024 · Medtronic has received approval of a US Food and Drug Administration (FDA) investigational device exemption (IDE) to initiate its pivotal clinical trial of the Prevail coronary …

Sep 7, 2025 · Explore Prevail Therapeutics' in-depth company profile, including funding details, key investors, leadership, and competitors.

At Prevail Therapeutics, we are developing novel gene therapies that target the root genetic causes of Parkinson’s disease and other neurodegenerative disorders.

Get today's Prevail Therapeutics stock news. We cover the latest Prevail Therapeutics headlines and breaking news impacting Prevail Therapeutics stock performance.

Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.

At Prevail, we are developing gene therapies designed to slow or stop the underlying causes of neurodegenerative and rare diseases. We are developing gene therapies that aim to target the …

May 15, 2024 · Prevail, the innovative new fitness app, has officially launched and is now available for download on the Apple App Store and Google Play Store....

Oct 2, 2025 · Join us in our mission to uphold the highest standards of journalism and stay informed with news you can trust.